[Perforating wounds of the cornea with prolapse of the iris; treatment without iridectomy].
H Gildemyn
https://pubmed.ncbi.nlm.nih.gov/7187257/Actively Recruiting
Led by Moumtzidou Maria Aikaterini · Updated on 2026-10-20
108
Participants Needed
1
Research Sites
13 weeks
Total Duration
This research aims to compare two different postoperative pain management strategies in adult women undergoing breast surgery. It evaluates whether a patient education-based analgesia approach can improve pain control and quality of recovery after hospital discharge compared with standard analgesic management. The study focuses on postoperative pain intensity and the overall recovery experience up to 90 days following surgery. Participants are assigned to one of two groups one receives a comprehensive analgesia strategy that includes patient education, discussion about pain management, non-drug measures, and a multimodal drug regimen involving paracetamol, dexketoprofen, and pregabalin. The other group receives standard postoperative analgesic care with written instructions and paracetamol. Rescue tramadol is available if needed. Treatments and education are provided from preoperative through the postoperative period. During the study, participants complete questionnaires assessing pain and recovery quality at specified times, including days 1 and 7, and at 1 and 3 months after surgery. Researchers monitor chronic neuropathic pain, emotional status, opioid use, and adverse events through 90 days. The trial includes follow-up via telephone and in-person visits to observe outcomes and safety over time.
CONDITIONS
Comparison of Two Postoperative Care Strategies After Breast Surgery
M
Maria Aikaterini Moumtzidou, MD
V
Vasileia Nyktari, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Moumtzidou Maria Aikaterini
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - Up to 30 days after surgery
Participants receive either a patient education-based postoperative pain management strategy with medications or standard analgesic care with written instructions and paracetamol.
Multiple visits and contacts during the first month after surgery
Duration - Up to 90 days after surgery
Participants complete questionnaires assessing pain, recovery quality, emotional status, opioid use, and adverse events up to 90 days after surgery.
Scheduled questionnaires and telephone follow-ups
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
H Gildemyn
https://pubmed.ncbi.nlm.nih.gov/7187257/Rex Park, Mohammed Mohiuddin, Ramiro Arellano...
https://pubmed.ncbi.nlm.nih.gov/37181639/Li Wang, Jared C Cohen, Niveditha Devasenapathy...
https://pubmed.ncbi.nlm.nih.gov/32611524/Zeeshan Ali, Zainab Ahsan, Nazneen Liaqat...
https://pubmed.ncbi.nlm.nih.gov/39169337/Roger Chou, Debra B Gordon, Oscar A de Leon-Casasola...
https://pubmed.ncbi.nlm.nih.gov/26827847/Philip J Chang, Arash Asher, Sean R Smith
https://pubmed.ncbi.nlm.nih.gov/34680339/David R Brenin, Jill R Dietz, Jennifer Baima...
https://pubmed.ncbi.nlm.nih.gov/32783121/Hance A Clarke, Varuna Manoo, Emily A Pearsall...
https://pubmed.ncbi.nlm.nih.gov/33987487/Kariem El-Boghdadly, Nicholas A Levy, William J Fawcett...
https://pubmed.ncbi.nlm.nih.gov/39319373/Rune Gärtner, Maj-Britt Jensen, Jeanette Nielsen...
https://pubmed.ncbi.nlm.nih.gov/19903919/Moumtzidou Maria Aikaterini
Lead Sponsor